ARDSLEY, N.Y. (AP) _ Acorda Therapeutics Inc. (ACOR) on Thursday reported fourth-quarter profit of $83 million.

On a per-share basis, the Ardsley, New York-based company said it had net income of $9.82. Losses, adjusted for non-recurring gains, came to $2.50 per share.

The drugmaker posted revenue of $38.2 million in the period.

For the year, the company reported that its loss narrowed to $99.6 million, or $12.32 per share. Revenue was reported as $153 million.

Acorda shares have climbed 64% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.78, a drop of 10% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACOR at https://www.zacks.com/ap/ACOR

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News